Login to Your Account



BioAlliance Pharma Files For EUR30M IPO On Euronext In Paris

By James Etheridge


Wednesday, November 30, 2005
PARIS - BioAlliance Pharma SA launched an IPO on Eurolist Compartment C of the Euronext stock exchange in Paris with the aim of raising €29.5 to €33.8 million and, in the words of its chairman and co-founder, Dominique Costantini, of "transmuting from a drug discovery company into a profitable pharmaceutical company." (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription